How Does 2016 WHO Criteria for Polycythemia Vera Contribute to Our Daily Practice? A Single-Center Study from Turkey

Background: We evaluated the frequency of subnormal erythropoietin levels, Janus kinase 2 (JAK2) V617F positivity and polycythemia vera (PV) in patients who did not meet World Health Organization (WHO) 2008 criterion for hemoglobin levels but were suggested to be investigated for PV in 2016 revision...

Descripción completa

Detalles Bibliográficos
Autores principales: Eren, Rafet, Sevinçoğlu, Bahar Funda, Doğan, Esma Evrim, Aydın, Demet, Nizam, Nihan, Demirel, Naciye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876427/
https://www.ncbi.nlm.nih.gov/pubmed/33603984
http://dx.doi.org/10.18502/ijhoscr.v14i4.4478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876427/
https://www.ncbi.nlm.nih.gov/pubmed/33603984
http://dx.doi.org/10.18502/ijhoscr.v14i4.4478

Ejemplares similares